阜阳在哪里看皮炎比较好阜阳哪家医院痤疮看的好,阜阳市皮肤科医院网址,阜阳皮肤病医院看痘痘贵吗,阜阳哪家美容院祛痘印好,阜阳那个皮肤科医院好,阜阳医院花斑癣科,阜阳丝状尤手术费多少钱

SAN FRANCISCO, April 20 (Xinhua) -- Apple Inc. on Wednesday reported record second fiscal quarter results that blow out analysts'expectations, citing strong demands for its products.For its fiscal 2011 second quarter ended on March 26, Apple posted net income of 5.99 billion U.S dollars or 6.4 dollars per share, compared with 3.07 billion, or 3.33 dollars per share a year ago. Its revenue reached 24.67 billion dollars, compare with 13.5 billion in the same period a year earlier.Analysts polled by Thomson Reuters gave an average estimate of 5.35 dollars earning per share on revenue of 23.3 billion."With quarterly revenue growth of 83 percent and profit growth of 95 percent, we're firing on all cylinders," said Steve Jobs, Apple's CEO. "We will continue to innovate on all fronts throughout the remainder of the year."As the most valuable business for the company, Apple sold 18.65 million iPhones in the second quarter, representing 113 percent unit growth over the year-ago quarter. In February, Apple announced that iPhone4 would come on Verizon network, enabling it to attract some 90 million Verizon subscribers to adopt the popular smartphone.The company sold 3.76 million Macs during the quarter, a 28 percent increase over the year-ago quarter, and 9.02 million iPods during the quarter, representing a 17 percent unit decline from the year-ago quarter.The company also sold 4.69 million iPads during the quarter, which is below analysts' projection. Analysts said Apple could have sold more tablets without supply constraints.Wall Street analysts estimated sales of iPad to reach about 6 million in the fiscal second quarter, alongside about 16 million iPhones and 3-4 million Macs.Apple also reported a gross margin of 41.4 percent compared to 41.7 percent in the year-ago quarter. Analyst said the decline of Apple's gross margins can be attributed to two reasons. One reason is the introduction of iPad in 2010 as it is a lower gross margin product than the iPhone. The other is the decline of iPhone margins over years.Supply chain related issues have been analysts' concern in the past quarter as Apple indicated in the Q1 earnings conference call that it could have sold more iPhones and faced some supply related issues. Meanwhile, the Japanese earthquake created more supply related issues for the company as its Japanese suppliers Mitsubishi Gas Chemical and Toshiba are both temporarily shut down to assess damage from the natural disaster.For the third fiscal quarter, Apple CFO Peter Oppenheimer gave an estimated revenue of about 23 billion and profit of 5.03 dollars per share.

BEIJING, March 3 (Xinhuanet) -- A new study suggested that regular use of painkiller ibuprofen may cut the risk of developing Parkinson's disease, according to Reuters reports.The research findings were published in the online edition of the journal Neurology on Wednesday and later will appear in the print edition on March 8.The study, which followed more than 136,000 U.S. men and women for six years, showed that people who took ibuprofen at least twice a week were 38 percent less likely to develop Parkinson's, a brain disorder that causes tremors and movement problems, compared to those who didn't take the pain reliever so often.Ibuprofen is sold in the U.S. as a non-steroidal anti-inflammatory drug (NSAID). But the study didn't prove that other NSAIDS, like aspirin or naproxen, could also cut the Parkinson's risk."Our study suggests ibuprofen could be a potential neuroprotective agent against Parkinson's," says lead researcher Dr. Xiang Gao from Harvard Medical School, "Protective effects are seen after taking ibuprofen two or more times a week. That's so-called regular use."However, he also warned that no proof has been found that ibuprofen itself can help ward off Parkinson's, and said that it's too early to recommend people to start taking ibuprofen to protect against the disorder.Gao said, "We just see an association, not some causal relationship."Besides, regular ibuprofen use has risks, like stomach bleeding and kidney damage.

ADDIS ABABA, Jan. 28 (Xinhua) -- The on-going political crisis in Cote d’Ivoire should be and can be solved peacefully, Chinese Envoy and Assistant Foreign Minister Liu Zhenmin told Xinhua here on Friday, ahead of the 16th African Union (AU) summit scheduled for Jan. 30-31.Liu was in the Ethiopian capital Addis Ababa, the headquarters of the 53-member African bloc, to attend the summit as special envoy of the Chinese government.Cote d'Ivoire has been trapped in a political impasse since the landmark presidential run-off held on Nov. 28. Both incumbent Laurent Gbagbo and opposition leader Alassane Ouattara claimed victory and swore themselves in as president, and formed their respective government.Gbagbo was backed by the country's Constitutional Council, while Ouattara has the support of the electoral commission and the international community including the United Nations (UN), the AU, the Economic Community of West African States (ECOWAS), the United States and France.China hopes various parties and stakeholders in Cote d’Ivoire can resolve their disputes through dialogues and consultations based on the interest of the country and its people, and maintain peace and stability, Liu said.A peaceful solution to the crisis is not only in the interests of the Ivorian people, but of the West African region as a whole, according to Liu.China appreciates the efforts made by the AU and ECOWAS to find a peaceful solution to the crisis, and will continue supporting Africa’s efforts to resolve the crisis peacefully, Liu said.According to the UN, more than 200 people have died from violence during the power struggle between Gbagbo and Ouattara.The 16th AU summit, to be held under the theme “Towards Great Unity and Integration Through Shared Values,” will gather heads of states and government from member states to discuss issues including Africa’s integration, and peace and security in the continent. The situation in Cote d’Ivoire, among others, is expected to top the agenda of the summit.

LOS ANGELES, April 2 (Xinhua) -- The United States could soon be faced with an epidemic of Non-Alcoholic Fatty Liver Disease ( NAFLD), one of the major contributing factors of chronic liver disease (CLD), the American Association for the Advancement of Science (AAAS) reported Saturday.If the current rates of obesity and diabetes continue for another two decades, the prevalence of NAFLD in the U.S. is expected to increase by 50 percent in 2030, AAAS said.The prediction is based on pre-existing clinical survey data over a 10 year period (1988-1994, 1999-2004 and 2005-2008), which included 39,500 adults from three survey cycles, according to the AAAS.Over the three cycles, the prevalence of NAFLD doubled from 5. 51 percent to 11 percent respectively. Furthermore, during the first survey cycle (1988-1994) 46.8 percent of all CLD's was related to NAFLD but by 2005-2008 this had increased to 75.1 percent. In addition, the prevalence of obesity and diabetes, the two key risk factors for NAFLD also steadily increased."If the obesity epidemic is anything to go by, the U.S. NAFLD epidemic may have a ripple effect worldwide," said Mark Thursz, Vice Secretary of the European Association for the Study of the Liver. "It is imperative that health systems continue to drive effective educational programs to reinforce awareness among the general public to alert them of the risks of obesity and promote the importance of diet and exercise."Non-alcoholic fatty liver disease is fast becoming one of the top concerns for clinicians due to the obesity epidemic and it's potential to progress to advanced liver disease which significantly impacts on overall liver-related mortality, Thursz said in remarks published by AAAS' website EurekAlert.org.NAFLD, considered as one of the major causes of morbidity and mortality worldwide, is the term used to describe fat build-up in liver cells in people who do not drink alcohol excessively. The disease is the most common persistent liver disorder in Western countries with an estimated overall prevalence of 20-30 percent, according to AAAS.NAFLD encompasses a spectrum of liver disease associated with insulin resistance, diabetes and obesity and as such people most at risk of NAFLD are those who are obese, have insulin resistance associated with diabetes, high blood pressure and cholesterol.

VIENNA, April 12 (Xinhua) -- A protein group has been identified as an "allergy multiplier" that causes food allergy, a symptom that could also accompany other allergies and produce serious consequences, Austrian researchers said Tuesday.The so-called non-specific lipid transfer proteins (nsLTP) are believed to be the causes of food allergy, a research team from the Medical University of Vienna said in a new report.These plant allergens are found not only in many fruits and vegetables, but also in cereals and some types of pollen. Due to their compact structures, they are not degraded in the gastrointestinal tract and can trigger immune reactions that cause severe allergic symptoms, said the report.The researchers believe that with nsLTP identified as an " allergy multiplier," diagnostic and treatment procedures could be adapted and improved.